Pay in 4 interest-free payments of $7.13 Learn more
Ships within 48 hours · Estimated delivery Aug 1 - Aug 6
Benefits (Research Focus) Triple receptor agonism studied for simultaneous activation of GLP-1, GIP, and glucagon receptors Body composition research investigated for fat-mass and lean-mass partitioning in DIO rodent models Glycemic endpoints examined for fasting glucose and HbA1c parameters in T2D research models Energy expenditure explored for glucagon-mediated thermogenic effects unique among incretin analogs Long-acting profile C20 fatty diacid albumin-binding chemistry for extended half-life research What Researchers Look At Receptor binding affinity and selectivity across GLP-1R / GIPR / GCGR cAMP activation curves in cell lines expressing each receptor subtype Food intake, body weight, and adipose-tissue change in DIO rodent models Hepatic steatosis, ALT/AST, and liver fat fraction endpoints Comparative pharmacology versus semaglutide, tirzepatide, and other incretin analogs Quick Specs Form: Lyophilized white powder Net Peptide Content: 120 mg per vial Quantity: 1 vial Appearance: White to off-white lyophilizate Reconstitution: Bacteriostatic or sterile water (added by the end researcher) Purity: 99% by HPLC Identity: MS-verified (per COA) Storage: Protect from light Identity Basics Compound: Retatrutide Synonyms: LY3437943
The best medication depends on your medical history, weight, cardiovascular risk, kidney function, insurance coverage, treatment goals, and individual response
Why this matters for peptide buyers The reconstitution solvent isn't a minor detail
More research will help determine if there is a link between expired tetracycline and kidney damage
Figure 5 shows that four subjects (15.1%) with weakness were improved in L-carnitine group, while no improvement was found in the placebo group
US$ 20.57
US$ 27.31
US$ 23.48
US$ 20.41
US$ 20.32
US$ 22.44
US$ 26.78
US$ 21.30
US$ 27.72
US$ 22.35
